The Impact of Frozen - Thawed Blastocyst Morphological Development and Blastocoele Re-expansion on Clinical Pregnancy Outcome After One Controlled Ovarian Stimulation Cycle Using REKOVELLE
Latest Information Update: 04 Nov 2021
At a glance
- Drugs Follitropin delta (Primary)
- Indications Female infertility
- Focus Therapeutic Use
- Sponsors Ferring Pharmaceuticals
- 12 Jan 2021 Status changed from recruiting to discontinued. Reason the study was stopped: Permanently terminated due to halt of recruitment due to COVID-19 pandemic.
- 10 Nov 2020 Planned End Date changed from 1 Sep 2020 to 30 Sep 2021.
- 10 Nov 2020 Planned primary completion date changed from 1 Sep 2020 to 30 Sep 2021.